The Family Firm’s Organon & Co OGN Stock Holding History

The Family Firm’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-466	Closed	-$9.64K	–	642
2024 Q2	$9.64K	Buy	+466	New	+$9.26K	﹤0.01%	684

Other funds holding OGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

SSM

Sound Shore Management Greenwich, Connecticut $2.98B AUM 22.67% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

DRZID

DePrince Race & Zollo Inc (DRZ) Winter Park, Florida $5.29B AUM 20.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

The Family Firm's OGN Position: Q3 2024 in Review

The Family Firm sold out of Organon & Co (OGN) in Q3 2024, closing a stake of 466 shares — an estimated $9.64K sold.

The Family Firm first reported a position in OGN in Q2 2024 and held it in 1 quarter. The position peaked at $9.64K in Q2 2024. 723 funds tracked by Wall St. Rank hold OGN as of Q3 2024.

The Family Firm reported no remaining Organon & Co position as of Q3 2024 after selling out during the quarter.
The Family Firm sold 466 Organon & Co shares in Q3 2024, an estimated $9.64K.
The Family Firm first reported a position in Organon & Co in Q2 2024 and held it in 1 quarter.
The Family Firm's Organon & Co position peaked at $9.64K in Q2 2024.
723 funds tracked by Wall St. Rank held Organon & Co as of Q3 2024.

Based on The Family Firm's 13F filing for Q3 2024, filed 17 Oct 2024.